Last updated 2026-07-20
- Raised Pre-Seed round led by Israel Biotech Fund, Dec 2020
Total raised
—
Last: Undisclosed Round 2021-01
Stage
Pre-Seed
Founded
2019
Headcount
5
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences
About
MemoryPlus is an Israeli startup that develops MP203, a drug to treat memory loss and MCI. The company's drug blocks the interaction of two proteins, PTEN and PSD-95, in the brain, helping patients to treat memory loss and age-dependent cognitive impairment and Alzheimer's disease.
Funding history · 1 round · — total
2020-12
Pre-Seed
Undisclosed
★ Israel Biotech Fund
Q&A
- What is MemoryPlus's primary focus?
- MemoryPlus is pioneering an innovative treatment targeting Alzheimer’s-related cognitive decline, leveraging a novel mechanism of action (MOA).
- What is the scientific basis for MemoryPlus's research?
- MemoryPlus's research is based on groundbreaking work from Prof. Shira Knafo, who discovered that the PTEN protein plays a critical role in memory decline by inhibiting neuronal activity.
- How does MemoryPlus's treatment aim to restore memory function?
- MemoryPlus aims to restore memory function by disrupting the interaction between PTEN and PDZ domain proteins.
- When was MemoryPlus founded?
- MemoryPlus was founded in April 2019.
- What is MemoryPlus's current employee count?
- MemoryPlus has 1-10 employees.
- Which sector does MemoryPlus primarily operate in?
- MemoryPlus's primary sector is Health Tech & Life Sciences.
- What was MemoryPlus's last funding round?
- MemoryPlus's last funding round occurred in January 2021, with Israel Biotech Fund as an investor.
- What is the current stage of MemoryPlus's product development?
- MemoryPlus's product is currently in the R&D stage.
Team · 3
Dr. Shira Knafo
Founder · Founder
Prof. Gal Ifergane
Founder · Founder
Ehud Netta
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
alzheimers-diseasepharmaceuticalsbiotechnologytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | www.memoryplus.biz |
|---|---|
| linkedin.com/company/105104554 |
Identifiers & details
| Founded | 2019 |
|---|---|
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516009982 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-04-08 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — charge (2) |
| Registered address | אופנהיימר 4 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-06 | סילוק שעבוד |
| 2026-05-06 | סילוק שעבוד |